ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,713,428 | +15.5% | 1,944,970 | +22.1% | 0.78% | +22.8% |
| Q2 2023 | $114,046,198 | -0.6% | 1,593,491 | -3.6% | 0.64% | -5.5% |
| Q1 2023 | $114,740,000 | -0.7% | 1,653,078 | -0.8% | 0.67% | -5.1% |
| Q4 2022 | $115,497,000 | +16.6% | 1,665,911 | -7.8% | 0.71% | +9.4% |
| Q3 2022 | $99,033,000 | -8.9% | 1,805,869 | +9.7% | 0.65% | -5.1% |
| Q2 2022 | $108,751,000 | -0.3% | 1,646,000 | +0.1% | 0.68% | +22.2% |
| Q1 2022 | $109,032,000 | +26.5% | 1,643,535 | +11.5% | 0.56% | +47.6% |
| Q4 2021 | $86,163,000 | -3.5% | 1,473,637 | -0.9% | 0.38% | -6.2% |
| Q3 2021 | $89,286,000 | +9755.0% | 1,486,626 | +9728.3% | 0.40% | +9975.0% |
| Q2 2021 | $906,000 | +30.9% | 15,126 | +8.2% | 0.00% | +33.3% |
| Q1 2021 | $692,000 | +189.5% | 13,983 | +191.9% | 0.00% | +200.0% |
| Q4 2020 | $239,000 | -67.6% | 4,790 | -64.2% | 0.00% | -75.0% |
| Q3 2020 | $737,000 | -0.1% | 13,387 | -4.1% | 0.00% | 0.0% |
| Q2 2020 | $738,000 | – | 13,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |